Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Breast 3Plasma cell 2Gastrointestinal 2Myeloid 1

Conditions

Breast Neoplasms 2Intermittent Fasting 1Advanced Hormone Receptor-Positive Breast Carcinoma 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Clinical Protocols × Breast × 1 year × Clear all
NCT07590583 2026-05-15

Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial

City of Hope Medical Center

Phase 1 Not yet recruiting
20 enrolled
Breast

Advanced Hormone Receptor-Positive Breast Carcinoma

NCT07440784 2026-02-27

Impact Of Intermittent And Water-Only Fasting On Gene Expression And Tumor Markers In Breast Cancer

Khyber Medical University Peshawar

Phase NA Active not recruiting
60 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

NCT05363189 2025-07-03

BestDIEP

Vastra Gotaland Region

Recruiting
380 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡